Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

Mucin 1 is a transmembrane glycoprotein which overexpresses cancer-specific epitopes (MUC1-CE) on pancreatic ductal adenocarcinoma (PDAC) cells. As PDAC is a low survival and highly aggressive malignancy, developing radioimmunoconjugates capable of targeting MUC1-CE could lead to improvements in PDA...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher, Eva Bezak
Formatua: Artikulua
Hizkuntza:English
Argitaratua: MDPI AG 2022-09-01
Saila:Cells
Gaiak:
pancreatic cancer
radioimmunoconjugates
mucin 1
C595
Sarrera elektronikoa:https://www.mdpi.com/2073-4409/11/19/2983

Internet

https://www.mdpi.com/2073-4409/11/19/2983

Antzeko izenburuak